A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.

Autor: Leffler DA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. dleffler@caregroup.harvard.edu, Kelly CP, Abdallah HZ, Colatrella AM, Harris LA, Leon F, Arterburn LA, Paterson BM, Lan ZH, Murray JA

Publikováno v: The American journal of gastroenterology [Am J Gastroenterol] 2012 Oct; Vol. 107 (10), pp. 1554-62. Date of Electronic Publication: 2012 Jul 24.